Edap Tms SA (NASDAQ:EDAP) shares were down 1.4% on Monday . The stock traded as low as $2.87 and last traded at $2.90, with a volume of 58,015 shares. The stock had previously closed at $2.94.

Separately, Zacks Investment Research raised shares of Edap Tms SA from a “sell” rating to a “hold” rating in a research note on Tuesday, July 19th.

The firm’s 50-day moving average price is $3.10 and its 200 day moving average price is $3.52. The company has a market cap of $82.32 million and a PE ratio of 17.43.

Edap Tms SA (NASDAQ:EDAP) last issued its quarterly earnings data on Thursday, August 25th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.12. On average, equities research analysts expect that Edap Tms SA will post $0.01 EPS for the current year.

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.